NCT06891950 - Butantan-DV Vaccine in Elderly Populations (DEN-04-IB) | Biotech Hunter

Enrollment

997

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

October 31, 2026

Conditions

Dengue

Interventions

BIOLOGICAL

Dengue 1,2,3,4 (attenuated) vaccine

Each 0.5 mL dose of the lyophilized formulation of Dengue 1,2,3,4 (attenuated) presents an approximate concentration of 103.0 PFU of each vaccine virus rDEN1Δ30-1545, rDEN2/4Δ30(ME)-1495,7163, rDEN3Δ30/31-7164, rDEN4Δ30-7132,7163,8308.

Trial Locations (1)

90610-000

Centro de Pesquisa 1 (POA01): Hospital São Lucas - PUCRS, Porto Alegre